Insulin degludec
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 844439-96-9 | Cat. No. | BCP23700 |
| Name | Insulin degludec | ||
| Synonyms | Tresiba; | ||
| SMILES | CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C | ||
| Chemical Name | |||
| Formula | C274H411N65O81S6 | M. Wt | 6103.97 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Insulin Degludec is an ultra-long-acting insulin analogue used for glycemic control in Diabetes Mellitus. Insulin and its analogues lower blood glucose levels by stimulating peripheral glucose uptake and by preventing hepatic glucose production. Compared to endogenous insulin, this product has an added hexadecanedioic acid to lysine at the B29 position which allows for the formation of multi-hexamers. When injected subcutaneously, these multi-hexamers form a drug depot store from which monomers are slowly and continuously absorbed into the circulation. As a result, Insulin Degludec has a protracted time action profile due to the delayed absorption from subcutaneous tissue depots into the systemic circulation. Compared to available long-acting analogues such as insulin glargine and insulin detemir, which have a duration of action of 20-24 hours, insulin degludec provides a consistent level of basal insulin over 42 hours with a low peak:trough ratio. Limitations of shorter acting analogues include more frequent dosing and less stable pharmacokinetics, which may negatively impact patient adherence and glucose control, particularly nocturnal control. Insulin Degludec was approved by the FDA in September 2015 as the product Tresiba, for use in providing glycemic control to adults with diabetes mellitus. | ||
Recommend Products
More >
-
-
-
-
-
-
-
-
Human Insulin, Solution
Cat. No.：BCP08894
No.：11061-68-0
Product Details -
BMS-754807
Cat. No.：BCP01926
No.：1001350-96-4
Product Details -
NVP-AEW541
Cat. No.：BCP02417
No.：475489-16-8
Product Details -
BMS-536924
Cat. No.：BCP02116
No.：468740-43-4
Product Details -
Linsitinib
Cat. No.：BCP01831
No.：867160-71-2
Product Details -
GSK1838705A
Cat. No.：BCP02847
No.：1116235-97-2
Product Details -
Tags:Insulin degludec supplier,Insulin degludec purchase,Insulin degludec manufacturer,Insulin degludec distributor,Insulin degludec cost,Insulin degludec buy,Insulin degludec for sale